Inverted papilloma of the urinary bladder: A molecular genetic appraisal

Ming Tse Sung, John Eble, Mingsheng Wang, Puay Hoon Tan, Antonio Lopez-Beltran, Liang Cheng

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Inverted papilloma of urinary bladder is an uncommon urothelial neoplasm. Its relationship to urothelial carcinoma is controversial. Little is known of the genetic abnormalities of inverted papilloma. To better understand its genetics, we analyzed 39 inverted papillomas, including 36 from men and three from women, for loss of heterozygosity (LOH). We examined four polymorphic microsatellite markers located on chromosome 9q32-33(D9S177), chromosome 9p22 (IFNA), chromosome 3p14.2 (D3S1300) and chromosome 17p13.1 (TP53), where genetic alterations occur frequently in urothelial carcinomas. Additionally, the status of inactivation of X-chromosome was examined in three female patients. The frequency of LOH in informative cases was 8% (3 of 37) for D9S177, 10% (4 of 38) for TP53, 8% (3 of 37) for IFNA and 8% (3 of 36) for D3S1300. In the analysis of X-chromosome inactivation, all three cases yielded informative results and one had nonrandom inactivation of X-chromosomes. The monoclonal origin demonstrated in the study of X-chromosome inactivation indicates the clonal process of inverted papilloma; however, the low incidence of LOH supports the view that inverted papilloma in urinary bladder is a benign neoplasm with molecular genetic abnormalities different from those of urothelial carcinoma.

Original languageEnglish
Pages (from-to)1289-1294
Number of pages6
JournalModern Pathology
Volume19
Issue number10
DOIs
StatePublished - Oct 21 2006

Fingerprint

Inverted Papilloma
X Chromosome Inactivation
Molecular Biology
Urinary Bladder
Loss of Heterozygosity
Chromosomes
Carcinoma
Microsatellite Repeats
Neoplasms
Incidence

Keywords

  • Clonality
  • Inverted papilloma
  • Loss of heterogosity
  • Neoplasia
  • Urinary bladder
  • X-chromosome inactivation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Inverted papilloma of the urinary bladder : A molecular genetic appraisal. / Sung, Ming Tse; Eble, John; Wang, Mingsheng; Tan, Puay Hoon; Lopez-Beltran, Antonio; Cheng, Liang.

In: Modern Pathology, Vol. 19, No. 10, 21.10.2006, p. 1289-1294.

Research output: Contribution to journalArticle

Sung, Ming Tse ; Eble, John ; Wang, Mingsheng ; Tan, Puay Hoon ; Lopez-Beltran, Antonio ; Cheng, Liang. / Inverted papilloma of the urinary bladder : A molecular genetic appraisal. In: Modern Pathology. 2006 ; Vol. 19, No. 10. pp. 1289-1294.
@article{3dee804f1483427faa7932d75a0db741,
title = "Inverted papilloma of the urinary bladder: A molecular genetic appraisal",
abstract = "Inverted papilloma of urinary bladder is an uncommon urothelial neoplasm. Its relationship to urothelial carcinoma is controversial. Little is known of the genetic abnormalities of inverted papilloma. To better understand its genetics, we analyzed 39 inverted papillomas, including 36 from men and three from women, for loss of heterozygosity (LOH). We examined four polymorphic microsatellite markers located on chromosome 9q32-33(D9S177), chromosome 9p22 (IFNA), chromosome 3p14.2 (D3S1300) and chromosome 17p13.1 (TP53), where genetic alterations occur frequently in urothelial carcinomas. Additionally, the status of inactivation of X-chromosome was examined in three female patients. The frequency of LOH in informative cases was 8{\%} (3 of 37) for D9S177, 10{\%} (4 of 38) for TP53, 8{\%} (3 of 37) for IFNA and 8{\%} (3 of 36) for D3S1300. In the analysis of X-chromosome inactivation, all three cases yielded informative results and one had nonrandom inactivation of X-chromosomes. The monoclonal origin demonstrated in the study of X-chromosome inactivation indicates the clonal process of inverted papilloma; however, the low incidence of LOH supports the view that inverted papilloma in urinary bladder is a benign neoplasm with molecular genetic abnormalities different from those of urothelial carcinoma.",
keywords = "Clonality, Inverted papilloma, Loss of heterogosity, Neoplasia, Urinary bladder, X-chromosome inactivation",
author = "Sung, {Ming Tse} and John Eble and Mingsheng Wang and Tan, {Puay Hoon} and Antonio Lopez-Beltran and Liang Cheng",
year = "2006",
month = "10",
day = "21",
doi = "10.1038/modpathol.3800667",
language = "English",
volume = "19",
pages = "1289--1294",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Inverted papilloma of the urinary bladder

T2 - A molecular genetic appraisal

AU - Sung, Ming Tse

AU - Eble, John

AU - Wang, Mingsheng

AU - Tan, Puay Hoon

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

PY - 2006/10/21

Y1 - 2006/10/21

N2 - Inverted papilloma of urinary bladder is an uncommon urothelial neoplasm. Its relationship to urothelial carcinoma is controversial. Little is known of the genetic abnormalities of inverted papilloma. To better understand its genetics, we analyzed 39 inverted papillomas, including 36 from men and three from women, for loss of heterozygosity (LOH). We examined four polymorphic microsatellite markers located on chromosome 9q32-33(D9S177), chromosome 9p22 (IFNA), chromosome 3p14.2 (D3S1300) and chromosome 17p13.1 (TP53), where genetic alterations occur frequently in urothelial carcinomas. Additionally, the status of inactivation of X-chromosome was examined in three female patients. The frequency of LOH in informative cases was 8% (3 of 37) for D9S177, 10% (4 of 38) for TP53, 8% (3 of 37) for IFNA and 8% (3 of 36) for D3S1300. In the analysis of X-chromosome inactivation, all three cases yielded informative results and one had nonrandom inactivation of X-chromosomes. The monoclonal origin demonstrated in the study of X-chromosome inactivation indicates the clonal process of inverted papilloma; however, the low incidence of LOH supports the view that inverted papilloma in urinary bladder is a benign neoplasm with molecular genetic abnormalities different from those of urothelial carcinoma.

AB - Inverted papilloma of urinary bladder is an uncommon urothelial neoplasm. Its relationship to urothelial carcinoma is controversial. Little is known of the genetic abnormalities of inverted papilloma. To better understand its genetics, we analyzed 39 inverted papillomas, including 36 from men and three from women, for loss of heterozygosity (LOH). We examined four polymorphic microsatellite markers located on chromosome 9q32-33(D9S177), chromosome 9p22 (IFNA), chromosome 3p14.2 (D3S1300) and chromosome 17p13.1 (TP53), where genetic alterations occur frequently in urothelial carcinomas. Additionally, the status of inactivation of X-chromosome was examined in three female patients. The frequency of LOH in informative cases was 8% (3 of 37) for D9S177, 10% (4 of 38) for TP53, 8% (3 of 37) for IFNA and 8% (3 of 36) for D3S1300. In the analysis of X-chromosome inactivation, all three cases yielded informative results and one had nonrandom inactivation of X-chromosomes. The monoclonal origin demonstrated in the study of X-chromosome inactivation indicates the clonal process of inverted papilloma; however, the low incidence of LOH supports the view that inverted papilloma in urinary bladder is a benign neoplasm with molecular genetic abnormalities different from those of urothelial carcinoma.

KW - Clonality

KW - Inverted papilloma

KW - Loss of heterogosity

KW - Neoplasia

KW - Urinary bladder

KW - X-chromosome inactivation

UR - http://www.scopus.com/inward/record.url?scp=33748872729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748872729&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800667

DO - 10.1038/modpathol.3800667

M3 - Article

C2 - 16862073

AN - SCOPUS:33748872729

VL - 19

SP - 1289

EP - 1294

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 10

ER -